Post-market Registry of the AMDS for the Treatment of Acute DeBakey Type I Dissection
Key facts
- Who runs it
- JOTEC GmbH
- Where
- Germany1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 301 people enrolled
- Started
- 12 Mar 2019
- Expected to end
- 30 Jun 2030
- Type of study
- Observational
- Treatments tested
- Ascyrus Medical Dissection Stent (AMDS)
- Record updated
- 9 February 2026
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- ≥18 and ≤ 80 years of age (male or female)
- One of the following diagnosed within 14 days:; Acute DeBakey type I dissection based on CT angiography; or; IMH based on CT angiography
Who cannot take part
- Uncontrolled systemic infection
- Known allergy(ies) to nitinol and/ or PTFE
- < 18 years of age or > 80 years of age (male or female)
- General Exclusion Criteria:
- Unwilling to comply with the follow-up schedule
- Refusal to give Informed Consent; Medical Exclusion Criteria:
- Uncontrollable anaphylaxis to iodinated contrast
- Patient in extreme hemodynamic compromise requiring cardiopulmonary resuscitation (CPR)
- Preoperative coma; Anatomical Exclusion Criteria:
- Any pathology of mycotic origin
- Subacute or chronic dissection of the ascending aorta and aortic arch (>14 days after the index event)
- Aortic fistulous communication with non-vascular structure (e.g. esophagus, bronchial)
- Extensive thrombus or calcification in the aortic arch as defined by CT angiography
- Excessive tortuosity precluding safe passage of the AMDS as defined by CT angiography
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The objective of this registry is to collect information on the performance and clinical benefits of the AMDS (Ascyrus Medical Dissection Stent) to treat patients with acute "DeBakey type I dissections" and with or without so called "preoperative clinically relevant malperfusion" and/or "intramural hematomas".
Read full original descriptionShow less
In a healthy aorta (the vessel that supplies blood to most of the body) the blood flows freely through the main lumen (a space inside the vessel where blood flows). The participants involved in this study have a tear that has separated the inner layer of the aorta wall and created a secondary channel (false lumen) in addition to the main channel (true lumen), and huts, the blood flows through both channels.
AMDS is a stent (a metal tube helping to keep the vessel open) that is placed in the descending thoracic aorta. AMDS is a medical device commercially available in the countries in which the study is being conducted and it is used as standard of care according to its indication.
Treatments tested
- Ascyrus Medical Dissection Stent (AMDS)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Post-market Registry of the AMDS for the Treatment of Acute DeBakey Type I Dissection: PROTECT Registry
- Record updated
- 9 February 2026